Published: 3 March 2026
Author(s): Richard Johnson, Ivan Gruev, Yoto Yotov, Peter Jackuliak, Claudio Borghi, Justyna Domienik-Karłowicz, Andrzej Tykarski, Krzysztof J. Filipiak, Milosz J. Jaguszewski, Krzysztof Narkiewicz, Marcin Barylski, Artur Mamcarz, Jacek Wolf, Zoltan Jarai, David Becer, Michal Vrablik, Dragoș Vinereanu, Marcin Wełnicki, Krystyna Widecka, Mieczyslaw Litwin
Section: Practice Guidelines
Hyperuricemia has traditionally been viewed primarily as a cause of gout; however, accumulating evidence indicates that elevated serum uric acid (sUA) is also associated with increased cardiovascular and renal risk. Recent epidemiological studies suggest that adverse outcomes may occur at sUA levels well below the classic crystal-based thresholds, particularly in patients with high cardiovascular risk.
